[Form 4] LABCORP HOLDINGS INC. Insider Trading Activity

Rhea-AI Filing Summary

Labcorp (LH) Form 4: EVP, President of Central Labs & International Megan D. Bailey reported equity transactions. On 11/01/2025, 370 shares of Common Stock were acquired (code M) from Restricted Stock Units. On 11/03/2025, 179 shares were surrendered (code F) at $257.84 to satisfy tax withholding.

Following these transactions, direct ownership stands at 3,594 Common Stock shares. Derivative holdings include 2,599 Restricted Stock Units that vest in three equal annual installments beginning on November 1, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bailey Megan D.

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Pres, Central Labs & Intl

3. Date of Earliest Transaction (Month/Day/Year)
11/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/01/2025		M		370	A	(1)	3,773	D
Common Stock	11/03/2025		F(2)		179	D	$257.84	3,594	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	11/01/2025		M			370	(3)	(3)	Common Stock	370	$0	2,599(4)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. The Restricted Stock Units vest in three equal annual installments beginning on November 1, 2025.

4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Sandra D. van der Vaart, Attorney-in-Fact for Megan D. Bailey	11/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Labcorp (LH) disclose in this Form 4?

An executive acquired 370 Common Stock shares via RSU settlement on 11/01/2025 and surrendered 179 shares on 11/03/2025 at $257.84 for tax withholding.

Who is the reporting person in Labcorp’s (LH) Form 4?

Megan D. Bailey, EVP, President of Central Labs & International.

How many Labcorp (LH) shares does the executive own after the transactions?

Direct ownership is 3,594 Common Stock shares after the reported transactions.

What RSU details are disclosed for Labcorp (LH)?

The executive holds 2,599 RSUs that vest in three equal annual installments beginning on November 1, 2025.

What was the price used for the tax withholding on 11/03/2025?

Shares were surrendered at $257.84 to satisfy tax withholding obligations.

What do the transaction codes M and F mean here?

Code M indicates acquisition from derivative conversion (RSUs); Code F indicates shares withheld to cover taxes.